Recurrent postural vasovagal syncope: Sympathetic nervous system phenotypes

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 5, 2011, Pages 711-718

  Vaddadi, Gautam ^a   Guo, Ling ^a   Esler, Murray ^a   Socratous, Florentia ^a   Schlaich, Markus ^a   Chopra, Reena ^a   Eikelis, Nina ^a   Lambert, Gavin ^a   Trauer, Thomas ^b   Lambert, Elisabeth ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Low blood pressure (hypotension); Norepinephrine; Sympathetic nervous system; Syncope; Vasovagal

Indexed keywords

DYNAMIN I; NORADRENALIN; NORADRENALIN TRANSPORTER; TRITIUM; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY POSTURE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; ISOTOPE DILUTION ASSAY; MALE; MICRONEUROGRAPHY; NEUROGRAPHY; NORMAL HUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECURRENT DISEASE; SUPINE POSITION; SYNCOPE; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; METABOLISM; PHYSIOLOGY;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; DYNAMIN I; FEMALE; HUMANS; MALE; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PHENOTYPE; RECURRENCE; SYMPATHETIC NERVOUS SYSTEM; SYNCOPE, VASOVAGAL; TYROSINE 3-MONOOXYGENASE;

EID: 84555203841     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.962332     Document Type: Article

References (30)

1. Vaddadi G, Lambert E, Corcoran SJ, Esler MD. Postural syncope: mechanisms and management. Med J Aust. 2007;187:299-304.
2. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D. Incidence and prognosis of syncope. N Engl J Med. 2002;347: 878-885.
3. Colman N, Nahm K, Ganzeboom KS, Shen WK, Reitsma J, Linzer M, Wieling W, Kaufmann H. Epidemiology of reflex syncope. Clin Auton Res. 2004;14(Suppl 1):9-17.
4. Mathias CJ, Deguchi K, Schatz I. Observations on recurrent syncope and presyncope in 641 patients. Lancet. 2001;357:348-353. (Pubitemid 32128541)
5. Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncoperelated hospitalizations in the united states. Am J Cardiol. 2005;95: 668-671. (Pubitemid 40255267)
6. Santhouse J, Carrier C, Arya S, Fowler H, Duncan S. A comparison of self-reported quality of life between patients with epilepsy and neurocardiogenic syncope. Epilepsia. 2007;48:1019-1022. (Pubitemid 46763424)
7. Sundlof G, Wallin BG. Muscle-nerve sympathetic activity in man: relationship to blood pressure in resting normo- and hyper-tensive subjects. Clin Sci Mol Med Suppl. 1978;4:387s-389s.
8. Esler M, Willett I, Leonard P, Hasking G, Johns J, Little P, Jennings G. Plasma noradrenaline kinetics in humans. J Auton Nerv Syst. 1984;11: 125-144. (Pubitemid 14074851)
9. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979;25:1461-1470. (Pubitemid 10204594)
10. Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, Agrotis A, Socratous F, Jennings G, Lambert G, Vaddadi G. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol. 2008; 1:103-109.
11. Todd ME. Development of adrenergic innervation in rat peripheral vessels: a fluorescence microscopic study. J Anat. 1980;131:121-133. (Pubitemid 10036544)
12. Jacob G, Ertl AC, Shannon JR, Furlan R, Robertson RM, Robertson D. Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol. 1998;84:914-921. (Pubitemid 28110621)
13. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand. 2003; 177:275-284. (Pubitemid 36337629)
14. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-934.
15. Eisenhofer G. Sympathetic nerve function: assessment by radioisotope dilution analysis. Clin Auton Res. 2005;15:264-283. (Pubitemid 41175846)
16. Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D. Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest. 1997;99:2736-2744. (Pubitemid 27259821)
17. Bechir M, Binggeli C, Corti R, Chenevard R, Spieker L, Ruschitzka F, Luscher TF, Noll G. Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation. 2003;107: 1620-1625. (Pubitemid 36397331)
18. Wasmund SL, Smith ML, Takata TS, Joglar JA, Li JM, Kowal RC, Page RL, Hamdan MH. Sympathoexcitation is attenuated during low level lower body negative pressure in subjects who develop pre-syncope. Clin Auton Res. 2003;13:208-213. (Pubitemid 36936664)
19. Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen KU, Kuusela TA, Diedrich AM. Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation. 1997; 96:2509-2513. (Pubitemid 27451338)
20. Vaddadi G, Esler MD, Dawood T, Lambert E. Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J. 2010; 31:2027-2033.
21. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci U S A. 1996;93:5166-5171. (Pubitemid 26162890)
22. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther. 2001;91:35-62. (Pubitemid 33055773)
23. Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol. 2004;5:133-147. (Pubitemid 38160256)
24. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985. (Pubitemid 20364820)
25. Thompson JM, O'Callaghan CJ, Kingwell BA, Lambert GW, Jennings GL, Esler MD. Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine betahydroxylase deficiency. J Auton Nerv Syst. 1995;55:198-206.
26. Schroeder C, Birkenfeld AL, Mayer AF, Tank J, Diedrich A, Luft FC, Jordan J. Norepinephrine transporter inhibition prevents tilt-induced presyncope. J Am Coll Cardiol. 2006;48:516-522. (Pubitemid 44093959)
27. Raj SR, Rose S, Ritchie D, Sheldon RS. The second prevention of syncope trial (Post II): a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J. 2006;151:1186 e1111-e1187.
28. Klingenheben T, Credner S, Hohnloser SH. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers. Pacing Clin Electrophysiol. 1999;22:276-281. (Pubitemid 29109268)
29. Flatmark T. Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol Scand. 2000;168:1-17. (Pubitemid 30128661)
30. Brignole M. International study on syncope of uncertain aetiology 3 (issue 3): Pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design. Europace. 2007;9:25-30. (Pubitemid 46157949)